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Abstract
Background: Value-based health care aims to optimize the balance of patient outcomes and health care costs. To
improve value in perinatal care using this strategy, standard outcomes must first be defined. The objective of this
work was to define a minimum, internationally appropriate set of outcome measures for evaluating and improving
perinatal care with a focus on outcomes that matter to women and their families.
Methods: An interdisciplinary and international Working Group was assembled. Existing literature and current
measurement initiatives were reviewed. Serial guided discussions and validation surveys provided consumer input.
A series of nine teleconferences, incorporating a modified Delphi process, were held to reach consensus on the
proposed Standard Set.
Results: The Working Group selected 24 outcome measures to evaluate care during pregnancy and up to 6months
postpartum. These include clinical outcomes such as maternal and neonatal mortality and morbidity, stillbirth, preterm
birth, birth injury and patient-reported outcome measures (PROMs) that assess health-related quality of life (HRQoL),
mental health, mother-infant bonding, confidence and success with breastfeeding, incontinence, and satisfaction with
care and birth experience. To support analysis of these outcome measures, pertinent baseline characteristics and risk
factor metrics were also defined.
Conclusions: We propose a set of outcome measures for evaluating the care that women and infants receive during
pregnancy and the postpartum period. While validation and refinement via pilot implementation projects are needed,
we view this as an important initial step towards value-based improvements in care.
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Background
Maternity care is rife with unwarranted variation. Rec-
ommendations for optimal prenatal care and childbirth
practices vary, even among advanced economies. Simi-
larly, the use of common interventions such as induction
of labor, continuous electronic fetal monitoring and
cesarean section is variable [1–3]. There are also dra-
matic differences in the cost of maternity care: in 2015,
the average standardized price to consumers of an un-
complicated birth in US dollars was $5312 in Australia,
as compared to $10,808 in the United States [4]. Such
variation presents an opportunity for health systems to
learn from each other in their efforts to improve effi-
ciency and effectiveness of clinical care. However, for
this learning to occur, a standardized framework for
evaluating pregnancy and postpartum care must be
established. Value-based health care (VBHC) provides
such a framework [5]. It defines value as the ratio of the
outcomes of care divided by the cost of achieving those
outcomes, with outcomes defined as the relevant end re-
sults of care from the perspective of the patient. By pro-
moting the comparison of outcomes and costs of care
using standardized metrics, VBHC enables providers and
others delivering care to understand best practices for de-
livering high-value care to women and their infants [5].
A key challenge to applying the VBHC framework to
pregnancy and childbirth has been the lack of standard-
ized outcome measures in the field. Most commonly col-
lected quality metrics in maternity care focus on health
care processes such as rates of cesarean sections and
prenatal care utilization. But, such measures do not dir-
ectly capture the outcomes of pregnancy and childbirth
foremost in most women’s minds – a healthy infant and
healthy mother [6–8]. Furthermore, operational defini-
tions for existing outcome measures vary considerably.
For example, postpartum hemorrhage may be defined by
the volume of blood loss [9, 10] or the need for the
transfusion of blood products [11, 12]. Standardized,
woman- and newborn-centered outcome measures, in-
cluding both clinical outcomes and patient-reported out-
comes (PROs), are needed to enable the use of VBHC to
improve pregnancy and postpartum care.
The International Consortium for Health Outcomes
Measurement (ICHOM) is a not-for-profit organization
that aims to facilitate the adoption of value-based health
care worldwide. As a first step in this process, it convenes
international Working Groups of clinicians, researchers,
and patients (“consumers”) to define standardized out-
come measure sets for evaluating value in specific condi-
tion areas, with a focus on the outcomes that matter most
to patients (www.ichom.org) [13]. The objective of the
work presented here, initiated by ICHOM, was to recom-
mend a minimum standard set of outcome measures and
associated case-mix factors to be collected during the
pregnancy and postpartum/newborn periods, to assist
health systems with evaluating and improving the value of
care they deliver.
Methods
Working group assembly and composition
ICHOM convened a Working Group composed of two
consumer representatives and 19 international experts in
various fields of perinatal and neonatal care, research
and patient advocacy. Within the realm of feasibility,
Working Group members were selected to provide bal-
anced expertise across geographies and clinical special-
ties, as well as representation from obstetric registries
and outcomes measurement initiatives (Table 1). The ac-
tivities of the Working Group were coordinated by a
Project Team consisting of a Working Group lead
(Franx), a Project Lead (Wissig), a Research Fellow
(Nijagal), and the ICHOM Vice President of Research &
Development (Stowell).
Work process and decision-making
The measure set was developed using a modified Delphi
method [14]. Between May 2015 and May 2016, the
Working Group convened for nine teleconferences.
Excluding the launch and final meetings, each telecon-
ference had a pre-determined, specific goal such as es-
tablishing the scope of the measure set, defining the
patient population, selecting outcomes and case-mix do-
mains, identifying appropriate definitions and/or mea-
sures for each domain, and determining when each
measure would be assessed during the pregnancy and
postpartum course. Based on the goal, the Project Team
reviewed relevant literature and current practices prior
to the teleconference and presented this information,
along with a specific proposal, during the teleconference
for group discussion. Detailed minutes of these discus-
sions were distributed following each teleconference to
Working Group members, who then voted on each item
of the Project Team’s proposal via an online survey.
Items required a 70% agreement among survey respon-
dents to be finalized into the measure set. Survey items
with less than 70% majority were either excluded from
the set or revised by the project team and re-presented
for discussion and voting at the next teleconference.
Selection of outcome domains, measures, and case-mix
factors
Multiple information sources were sought to support the
consideration of outcome domains to be included. In
addition to reviewing outcomes included in regional
perinatal health registries and quality indicator sets, a
comprehensive literature review was performed using
search terms focused on quality outcomes or indicators,
birth experience and health-related quality of life
Nijagal et al. BMC Health Services Research          (2018) 18:953 Page 2 of 12
(HRQoL). This resulted in a comprehensive list of both
clinical and woman-centered outcomes. [Additional
file 1]. A serial guided discussion among five pregnant
and postpartum women was also conducted to identify
additional outcomes that had not emerged from the
literature search. Participants in this focus group were
asked to reflect on their most significant experiences
during the pregnancy, birth and postpartum periods as
a mechanism to explore what participants’ felt were
their most important goals of care. The group repre-
sented a variety of ages, parities, phases in the care
cycle (prenatal vs. postpartum), clinical experiences
(routine vs. complicated), and nationalities. We recognize
that this did not provide a representative sample of
pregnant and postpartum women globally; however,
our aim was to gather further information to support
Table 1 Working Group members by country and specialty, including organizations and data initiatives represented
Country Specialty Working Group member Organization Data initiatives
Australia Consumer Representative Tessa Kowaliw South Australian Maternity
Reform Association (SAMRA) Inc.
Obstetrics and Gynecology Rod Petersen Women and Children’s Health
Network
Italy Midwifery Anna Marie Speciale American College of Nurse-
Midwives
Malaysia Obstetrics and Gynecology J Ravichandran R Jeganathan Sultanah Aminah Hospital, Johor
Ministry of Health, Malaysia
National Obstetrics Registry
Shamala Devi Karalasingam National Clinical Resarch Centre,
Ministry of Health Malaysia
National Obstetrics Registry
Netherlands Midwifery Marije Lamain-de Ruiter University Medical Center Utrecht
Neonatology Floris Groenendaal University Medical Center Utrecht
Irwin Reiss Erasmus Medical Center
Obstetrics and Gynecology Gouke Bonsel Erasmus Medical Center Mind2Care Foundation
Arie Franx University Medical Center Utrecht Indicators Committee of the
Dutch Society of Obstetrics and
Gynecology (NVOG)
Netherlands Perinatal Registry
(PRN-foundation)
South Africa Obstetrics and Gynecology Stefan Gebhardt Stellenbosch University and
Tygerberg Hospital
Sweden Obstetrics and Gynecology Isis Amer-Wahlin Karolinska Institute
United Kingdom Obstetrics Matthew Coleman University Hospital Southampton
James Duffy Balliol College, University of
Oxford
Core Outcomes in Women’s
Health (CROWN) initiative
United States Consumer Representative Meridith Greene Massachusetts General Hospital
Health Policy Carol Sakala National Partnership for Women
& Families
National Quality Forum’s (NQF):
• MAP Medicaid Child Health Task
Force
• Perinatal and Reproductive
Health Standing Committee
Health Psychology Rachel Thompson The Dartmouth Institute for Health
Policy and Clinical Practice
The Queensland Center for
Mothers and Babies
Maternal and Fetal Medicine Elliott Main CMQCC (California Maternal
Quality Care Collaborative)
California Maternal Data Center
(CMDC)
Marlin Mills Hoag Memorial Hospital
Michelle Owens University of Mississippi Medical
Center, ACOG
Obstetrics and Gynecology Allyson Brooks Women’s Health Institute at Hoag
Memorial Hospital Presbyterian
Tracy Flanagan Kaiser Permanente
Malini Nijagal University of California San
Francisco, Zuckerberg San
Francisco General Hospital
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decision-making and guide prioritization of outcome
domains by the Working Group.
The comprehensive list of potential outcome domains
was presented to the Working Group for discussion dur-
ing a teleconference meeting. Working Group members
were then asked to score each potential outcome on the
GRADE scale via electronic survey [15]. Outcome do-
mains thought to be “critical” (scored between 7 and 9)
by at least 70% of the respondents were included in the
set. Those scored as “low importance” (between 1 and 3)
by at least 70% of respondents were excluded. The
remaining domains were modified and re-presented for
a second round of voting. Domains meeting neither the
inclusion nor exclusion criterion after a second round of
voting were discussed again by the Working Group and
then presented for a final binary vote.
A similar protocol was followed to define appropriate
measures for each domain, and to select the case-mix
factors included in the set. Prior to teleconferences, the
project team reviewed the literature to identify potential
measures for each domain, and to compile a comprehen-
sive list of demographic, social, and clinical factors asso-
ciated with the selected outcomes. The final outcome
measures and case-mix factors were then finalized
through the process of Working Group discussion via
teleconference, followed by voting via electronic survey.
Determining timeline and process for measurement
To determine when and how each outcome measure
and case-mix factor would be assessed during the preg-
nancy to postpartum continuum, the Project Team used
the same process: current practices were researched, op-
tions discussed with the Working Group during telecon-
ferences, and electronic surveys were administered for
voting.
Consumer validation surveys
To ensure robust consumer input in the development of
the measure set, we solicited feedback from pregnant
and postpartum women around the world via an an-
onymous online survey. Quorum Review IRB issued a
written determination of exemption for the ICHOM Pa-
tient Advisory Group in Pregnancy and Childbirth. A
link to the survey was distributed within Working Group
members’ networks via social media, with no inclusion
or exclusion criteria for participation. The survey pre-
sented, in lay terms, the outcome domains voted in for
inclusion by the Working Group. Respondents were
asked to score included domains according to their im-
portance on the GRADE scale and were given an oppor-
tunity at the end of the survey to suggest any missing
outcomes. Survey responses and suggestions were pre-
sented to the Working Group to inform their conclusion
on the generalizability of the consumer advisory group
discussion themes.
Open review process
To also allow for input from healthcare professional stake-
holders outside of the formal Working Group, a 4-week
open review period was held prior to the last Working
Group teleconference. The Project Team identified key
stakeholders representing provider organizations, payers,
consumer advocacies, and other individuals expressing
interest in the measure set via the ICHOM website. Each
was sent an overview of the set with links to the full detail
Reference Guide and a feedback survey. The results of this
survey were presented to the Working Group during the
final teleconference call.
Results
Response rates
Response rates for the seven post-teleconference surveys
present to Working Group members were 82, 82, 73, 73,
77, 77 and 73% respectively. Group size fluctuated due
to the late addition of some members and occasional un-
availability of others. All members received call minutes
and were kept abreast of the Working Group’s progress.
For post-teleconference surveys that involved two
rounds of voting, the response rate for the second round
is presented here.
Scope
The measure set covers key outcomes of care for all
women and their infants from the first prenatal visit
through six months postpartum. The endpoint was se-
lected as a pragmatic compromise: the Working Group
recognized that while important outcomes may not
emerge until later than 6 months after birth [16], the re-
sponse rates for patient questionnaires decreases over
time and, therefore, a much later endpoint may not be
feasible [17, 18]. Pregnancies with pre- or postnatally di-
agnosed significant congenital anomalies are excluded
from measurement.
Patient focus group discussion
All five participants had one or more children; one was
pregnant at the time of the discussion and four were
postpartum.
Seven major themes emerged from the discussion.
1) The importance of having access to trusted
information.
2) A desire to be involved in shared decision making.
3) A desire for immediate contact with their baby after
delivery.
4) Mental health during the pre- and postnatal periods.
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5) Anxiety about early pregnancy loss and the health
of the unborn child in the first trimester.
6) A need for greater breastfeeding support.
7) Concerns about adapting to their new role as a
mother.
These themes were presented to the working group
during the second teleconference call.
Outcome domains and measures
Outcome domains and definitions/measures included in
the set are presented in Table 2, along with the percent-
age of responding Working Group members who agreed
with the inclusion of the domain. Domains and mea-
sures for which there was significant discussion within
the Working Group are discussed below.
Survival
Maternal mortality, stillbirth (fetal death), and neonatal
death were considered key outcomes to include in the
set, and the World Health Organization (WHO) defini-
tions were selected as the international standard for each
[19, 20]. However, low rates of maternal mortality within
high-income countries may prohibit meaningful compar-
isons of this outcome between hospitals or health care
provider organizations [11, 12, 21]. Therefore, we in-
cluded maternal mortality in the measure set to encour-
age tracking and auditing of each case, but stipulate that
rates should not be used for intra-national comparisons.
Morbidity
The working group unanimously voted to include the
domain “severe maternal morbidity”; however, defining
appropriate measures of this broad domain proved chal-
lenging. Most obstetric registries and regulatory bodies
measure maternal morbidity by counting the occur-
rences of a comprehensive list of complications and ad-
verse events, yet there is little consistency in which
events are included [22, 23]. Furthermore, as with ma-
ternal mortality, rates of these events at individual hospi-
tals or provider organizations are often too low to allow
for meaningful comparisons.
Therefore, the Working Group selected four measures
that represent the common endpoints of the leading
causes of preventable maternal mortality worldwide, i.e.
hypertensive disease, venous thromboembolism, sepsis,
and obstetrical hemorrhage [24]. These included admis-
sion to an intensive care unit or transfer to another facil-
ity for intensive care, maternal length of stay, admission
to the hospital during the postpartum period (i.e. re-
admission), and postpartum blood transfusions. These
proxy measures aggregate across complications and ad-
verse events to provide simple, standardized metrics for
comparisons. The Working Group recognizes that the
incidence of specific complications and adverse events
must be tracked to properly interpret these proxy out-
comes. In addition, although similar measures have been
shown to correlate well with more traditional measures
of maternal morbidity, the Working Group recommends
testing and evaluation of these measures before broad
adoption [25].
Similar rationale motivated the selection of measures
to represent severe newborn morbidity: newborn length
of stay (corrected for prematurity) and oxygen depend-
ency for greater than 24 h. The Working Group felt that
significant morbidity would be better measured in an
international setting using oxygen dependency rather
than neonatal intensive care unit (NICU) admission, as
no universally accepted definitions for NICU levels exist
and NICU use varies based on local circumstances and
resources. This is even the case in a small country such
as The Netherlands (www.perined.nl) where the pres-
ence or absence of intermediate care units leads to dif-
ferent criteria for admission to the NICU between
tertiary hospitals. The outcomes of preterm birth and
birth injury were also included in the measure set. Pre-
term birth, the leading cause of infant morbidity and
mortality, is separated into spontaneous and iatrogenic
(e.g. in case of severe maternal disease), as higher than
expected rates of either may signify areas for improve-
ment [26]. For birth injury, an inclusive definition was
selected to include clavicular and brachial plexus injuries
in addition to other more severe injuries, as these are not
uncommon, may have significant long-term consequences
for infants, and are distressing to families [27–29].
Domains representing patient-reported health and well-
being
Overall health and wellbeing measures are most appro-
priately captured by self-report using Patient Reported
Outcome Measures (PROMs). However, little work has
been done on the use of PROMs in routine maternity
care and none of the registries reviewed for this work in-
clude patient-reported measures [30]. To recommend
measures for these important outcomes, we relied on
PROMs that have been shown to successfully measure
the outcome of interest in a general, non-maternity
population (e.g. the Patient-Reported Outcomes Meas-
urement Information System (PROMIS) Global to meas-
ure HRQoL, and the Patient Health Questionnaire-2
(PHQ-2) to measure postpartum depression) or that have
proven useful in research studies (e.g. the Mother-Infant
Bonding Scale (MIBS) to assess mother-infant attachment
and the Breastfeeding Self-Efficacy Scale – Short Form
(BSES-SF) to identify women struggling with breastfeed-
ing). In some cases, individual questions were modified
from maternity specific regional or national surveys, such
as the National Perinatal Epidemiology Unit in the UK
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Table 2 Outcome domains and definitions included in the Standard Set
Category and outcome domain Outcome definition/measure Data Source Agreementa
Survival
Maternal death Death of a female from any cause related to or aggravated by pregnancy or its
management (excluding accidental or incidental causes) during pregnancy and
childbirth or within 42 days of pregnancy termination, irrespective of site or
duration of the pregnancy b
A 94%
Still birth Pregnancy loss at or after 28 + 0 weeks gestation of a birth weight of greater or
equal to 1000 g
A 87%
Neonatal death Death of a live born neonate up to 28 days of life A 100%
Severe Maternal Morbidity
Maternal need for intensive care Admission to an ICU or a unit that provides 24-h medical supervision and is able to
provide mechanical ventilation or continuous vasoactive drug support at any point
during pregnancy through 42 days postpartum for pregnancy or childbirth related
complications.
A 100%
Maternal length of stay Number of consecutive days in the hospital from delivery to discharge A 100%
Late maternal complication Admission or re-admission within the first 42 days postpartum for childbirth related
complications c
A 100%
Transfusion Any transfusion of red blood cells within the first 42 days postpartum A 100%
Neonatal Morbidity
Spontaneous preterm birth Live birth at < 37 +0 weeks gestation occurring after spontaneous labor or rupture
of membranes
A 89%
Iatrogenic preterm birth Cesarean or labor induction before < 37 weeks + 0 gestation excluding those
occurring after spontaneous labor or rupture of membranes
A 89%
Oxygen dependence Administration of O2 by any route for greater than 24 h at any point during the
first 28 days of life
A 88%
Neonate length of stay Number of consecutive days in hospital from birth through 28 days of life A 88%
Birth injury Subdural and cerebral hemorrhage, massive epicranial subaponeurotic hemorrhage,
other injuries to skeleton due to birth trauma, injury to spine and spinal cord due
to birth trauma, injury to brachial plexus due to birth trauma, other cranial and
peripheral nerve injuries due to birth trauma in single live-born neonates
A 81%
Patient-reported Health Status
Health related quality of life Tracked via the PROMIS Global10 PR 81%
Incontinence Tracked via either the ICIQ-SF or Wexner PR 86%
Pain with intercourse Tracked via PROMIS SFFAC102 PR
Breastfeeding
Success with breastfeeding Please indicate how you are feeding your baby. My baby has received only breast
milk in the past 7 days. This may include breast milk in a bottle/My baby has
received a combination of breast milk, formula, or water in the past 7 days/My baby
has received only formula, water, or other liquids but not breast milk in the past 7
days.
PR 83%
Confidence with breastfeeding How confident do you feel about breastfeeding? Not at all confident/Not very
confident/ Somewhat confident/Confident/Very confident.
PR 81%
Option to track via the BSES-SF 72%
Role Transition
Mother-infant attachment Tracked via the MIBS PR 72%
Confidence with role as a mother How confident [will you feel when your baby is born/do you feel about looking
after your baby]? Not at all confident/Not very confident/Somewhat confident/
Confident/Very confident.
PR 94%
Mental Health
Postpartum Depression Assessed via the PHQ-2 with optional follow-up with the EPDS PR 88%
Satisfaction with Care
Satisfaction with the results of care How satisfied are you with the results of your care during [your pregnancy/your
labor and birth/the months after your baby was born]? Very unsatisfied/Unsatisfied/
PR 81%
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and the Queensland Centre for Mothers & Babies in
Australia [31, 32]. Validated PROMs were selected based
on their domain coverage, psychometric properties, valid-
ity, feasibility to implement and clinical interpretability,
according to guidelines from the International Society for
Quality of Life Research (ISOQOL) [33].
Birth experience
The quality of the birth experience was not an outcome
originally voted for inclusion in the measure set by the
Working Group. However, there was unanimous agree-
ment to add satisfaction with the birth experience fol-
lowing analysis of the consumer validation survey
responses. Notably, although 84% of validation survey
respondents agreed that the set “captures the most im-
portant outcomes that matter or have mattered to you”,
thematic analysis of free-text responses to the prompt “if
not, what would you add” suggested a need to better
understand the quality of the birth experience from the
woman’s perspective. The Birth Satisfaction Scale - Re-
vised (BSS-R), a validated 10-item questionnaire, was se-
lected to capture this information [34]. (Details of the
consumer validation survey are presented in Additional
file 2.)
Case-mix factors
A number of patient characteristics and risk factors are
known to influence the outcomes presented above. To
ensure fair comparisons across providers with diverse
patient populations, the Working Group identified and
defined key case-mix factors to include in the set. Fac-
tors selected for inclusion were considered to have a
strong and independent effect on the outcomes included
in the set, and to be practical for collection in an inter-
national setting. All case-mix factors and definitions are
presented in Table 3, along with the percent of respond-
ing Working Group members who agreed upon their
inclusion. The outcome of preterm birth also allows for
stratification of other maternal and infant outcomes that
may be impacted by gestational age at delivery.
Timeline and process for measurement
The timeline for measurement was constructed based on
clinical relevance and feasibility (Fig. 1). First, time-
frames for measuring each outcome were identified
based on clinical appropriateness. Next, recommended
care schedules from several countries were analyzed to
identify common time points at which women engage
with maternity care. Tying patient-reported data collec-
tion to common clinic appointments allows collection to
happen within the clinic and use of the data within clin-
ical care. The 6-month postpartum data collection point
is beyond the time frame of standard maternity care
internationally and requires data to be collected from
women via mail or electronic platforms.
Minimizing the length of patient surveys was a priority
to reduce survey burden on women. Recognizing that
not all women desire to breastfeed, the BSES-SF was
made an optional measure to identify those who may
benefit from additional support in the hospital or early
postpartum period [35]. The Working Group also rec-
ommended a hierarchical question design when asses-
sing outcomes affecting only a subset of women. For
example, questions about the nature and frequency of
urinary or fecal incontinence are burdensome for women
without incontinence. Therefore, a single ICHOM-defined
incontinence screening question is presented to all women
with only those reporting symptoms going on to complete
validated PROMs assessing symptom severity. Similarly,
the Edinburgh Postnatal Depression Scale (EPDS) is in-
cluded as an optional follow-up measure for those who
screen positive on the shorter PHQ-2 [36–38]. Both mea-
sures have been validated for the pregnancy and the post-
natal periods: the PHQ-2 is a practical and sensitive
Table 2 Outcome domains and definitions included in the Standard Set (Continued)
Category and outcome domain Outcome definition/measure Data Source Agreementa
Neither satisfied nor dissatisfied/Satisfied/Very satisfied.
Healthcare Responsiveness
Confidence as an active participant
in healthcare decisions
Thinking about your care during [your pregnancy/your labor and birth/the months
after your baby was born]…
Were you given information about your choices for maternity care?
Were you given enough information to help you decide about your care?
Were you given information at the right time to help you decide about your care?
No/To some extent/Yes
PR 94%
Confidence in healthcare providers Do you have confidence and trust in the staff caring for you? No/To some extent/Yes. PR 89%
Birth Experience
Birth Experience Assessed via the BSS_R PR 100%
aPercentage agreement among survey respondents to include outcome domain in set
bThis outcome should be tracked by all providers but will not be used for comparisons between providers or provider organizations
cExcludes initial hospitalization for childbirth
For data source: A administrative data, PR patient-reported data
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measure to detect perinatal depression, while the EPDS
provides higher specificity [36]. Of note, while the Work-
ing Group advocated for postpartum depression screening
by all maternity care providers, they emphasized that a re-
sponse protocol must be in place to identify and treat
individiuals who screen positive in a timely manner.
Consumer validation surveys and open review feedback
A total of 105 consumer validation surveys and 17
complete responses to the open review feedback survey
were received from across all continents except South
America. Responses were generally positive. For the open
review feedback, a median score of 4 (“agree”) on a
5-point scale from “strongly disagree” to “strongly agree”
was obtained for statements about the scope of the meas-
ure set, the appropriateness of the included measures, and
its ease of implementation. 94% of respondents reported
that they would recommend implementation of the meas-
ure set to their colleagues. Specific survey comments were
presented to the Working Group for discussion but re-
sulted in no changes to the measure set.
Discussion
The ICHOM Working Group on Pregnancy and Child-
birth proposes a streamlined set of 24 outcome mea-
sures that are practical to measure, are internationally
Table 3 Case-mix variable domains and definitions included in the Standard Set
Category and case-mix
factor domain
Case-mix factor definition Data Source Agreementa
Demographic Factors
Age Age at time of delivery A 100%
Education level Please indicate the highest level of schooling completed. None; Primary; Secondary; Tertiary
(university or equivalent).
PR 94%
Race/ethnicity Race/ethnicity as defined locally. Varies by country and should be determined by country (not
for cross country comparison).
PR 88%
Social Support SIMSS, How many people do you have near you that you can readily count on for help in time
of difficulty such as to watch over children or pets, give rides to the hospital or store, or help
when you are sick?
PR 75%
Parity Have you given birth before? This includes both vaginal births and Cesarean sections (operations
to remove your baby from your abdomen). Please do not count miscarriages or births that
happened before 20weeks (5months) of pregnancy.
PR 100%
Obstetric and Medical History
Obstetric history If you have been pregnant before, have you experienced any of the following in previous
pregnancies? Please mark all that apply. This is my first pregnancy. A baby born early, more
than 3 weeks before his or her due date. Bleeding so much during pregnancy, birth, or after
birth that you needed to be given blood. A Cesarean section (operation to remove your baby
through your abdomen). Loss of a pregnancy after 20 weeks (5 months) of pregnancy.
PR 100%
Medical history BEFORE you got pregnant, did a doctor, nurse, or other health worker tell you that you had any
of the following health conditions? Tick all that apply: Diabetes; high blood pressure or
hypertension; a mental health disorder such as depression, anxiety, bipolar disorder or
schizophrenia.
PR 94%
Multiple gestations Are you pregnant with: One baby, two babies (twins), three or more babies (triplets or higher). PR 100%
BMI What was your weight IMMEDIATELY before your pregnancy? (Weight in lbs. or kgs). What is
your height? (Height in ft. or meters).
PR 94%
Substance use Tobacco use, drug use, or alcohol use complicating pregnancy PR 94%
Congenital anomaly Diagnosis of a neonate with any of the following within 28 days of birth: Anencephaly, Spina
bifida occulta, Meningo (myelo)cele, Hydrocephaly/holoprosencephaly without neural tube
defect, Encephalocele, Neuromuscular abnormalities, Transposition of the great artieris,
Tetralogy of Fallot, Hypoplastic left heart, Coarctation of the aorta, Complex cardiac
malformation, Choanal atresia, Congenital malformation trachea, Lung hypoplasia, Hydro/
Chylothorax, Congenital diaphragmatic hernia, Extrophia vesicase, Bilateral renal agenesis,
Gastroschizis, Omphalocele, Trisomy 13, Trisomy 18, Trisomy 21, Congenital malignancy
A 94%
Treatment Variables
Facility Type Indicate where the birth took place (using local definitions for NICU levels): Birth at home or
birth center, birth at a hospital with a level 1 or 2 NICU, birth at a hospital with a level 3 NICU.
A 94%
Route of delivery Indicate the route of birth: spontaneous vaginal delivery, forceps or vacuum vaginal delivery,
delivery by cesarean section.
PR 82%
aPercentage agreement among survey respondents to include case-mix factor
For data source: A administrative data, PR patient-reported data
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appropriate, and represent the goals of care that matter
to women and their families. An associated set of
case-mix factors is included to allow for outcome com-
parisons. We expect that measurement of these out-
comes for every pregnancy, birth, woman and infant,
when validated in diverse international settings, will fa-
cilitate communication between women and their care
providers, incentivize and empower providers to im-
prove care, and eventually, allow for benchmarking so
that women and families, providers, and payers can
make informed decisions about their health care spend-
ing and treatment options [39]. .Thus, we recommend
this proposed measure set as an important step to
achieving VBHC in pregnancy and postpartum care. A
reference guide that includes the detailed measures,
timeline for collection and patient-reported data ques-
tionnaires is publicly available through the ICHOM web-
site to assist clinicians with starting measurement within
their settings [40].
Of course, not all outcomes included in this set may be
appropriate for making meaningful comparisons. In the
case of rare outcomes, such as maternal mortality in de-
veloped countries, or outcomes that are determined
largely by factors beyond care delivery processes, variation
between providers may not be meaningful. Nevertheless, a
comprehensive measure set that represents the most im-
portant outcomes from the perspective of women is crit-
ical for health systems to understand the overall goals of
care and identify opportunities for improvement.
Measuring the outcomes in this set can immediately
help healthcare providers both improve communication
with patients and guide their quality improvement efforts.
For example, urinary and/or fecal incontinence is experi-
enced by up to 31% of women 6months postpartum [41];
but despite a significant impact on health-related quality
of life, many women do not report their symptoms [42,
43]. By giving women the opportunity to do so,
patient-provider communication about this issue can im-
prove and care options be explored. In addition, when
measured on a large scale, providers may identify a need
to change care processes that may contribute to this
outcome.
As a result of our focus on outcomes that matter most
to women, PROMs and patient-reported experience mea-
sures (PREMs) form a significant portion of the measure
set. Traditionally, validated patient-reported measures
have been used in the obstetrical research setting (e.g. to
determine the prevalence of specific outcomes and evalu-
ate their impact on HRQoL [42]) and within clinical prac-
tices on a limited basis (e.g. the EPDS) [38]. However,
despite international interest in using patient-reported
outcome measurement to drive clinical decisions and im-
prove the care of individual patients, neither PROMs nor
PREMs are included in any major perinatal registry or
quality measure set that we reviewed [44]. We hope that
our proposed measure set will facilitate the use of these
measures more widely in maternity care.
Through this work, we also identify a set of case-mix fac-
tors to support the development of outcomes comparisons.
The need for such a methodology in maternity care is well
established [45]. Without appropriate risk adjustment, fa-
cilities may be reluctant to contribute data to benchmark-
ing efforts or be transparent about their outcomes [46].
Some case-mix factors, such as obstetrical and medical his-
tory, may be most appropriately used to risk-adjust out-
comes; others, such as facility type and delivery route, may
be more appropriate to use in stratified outcome compari-
sons. Our identification of an evidence-based set of
case-mix factors is an important step towards useful out-
comes measurement and comparisons.
While our measure set focuses on outcomes of care,
we do not suggest that process measurement should be
Fig. 1 Timeline for ICHOM Pregnancy and Childbirth Standard Set data collection. The following timeline illustrates when Standard Set variables
should be collected from patients, clinicians or administrative sources
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abandoned. Evaluation of outcomes provides a frame-
work for interpreting process data and identifying pro-
cesses that can be improved. For example, multiple
registries include “cesarean sections among low-risk
mothers” as a quality metric in response to a concerning
rise in the use of this procedure [8, 47, 48]. However, the
optimal rate for this metric is unclear [49]. Assessments
of overuse versus underuse of this procedure have been
guided by the goal of preventing perinatal mortality and
morbidity, but have not considered other important out-
comes that may be impacted by the delivery route, such
as time to recovery, difficulty with breastfeeding, and in-
continence [50, 51]. By measuring a holistic set of out-
comes in addition to cesarean rates, institutions can
more comprehensively evaluate the impact of their
cesarean rates on maternal and neonatal wellbeing.
Strengths and limitations
Our work represents a unique contribution to health
systems and providers seeking to improve perinatal care
delivery. To our knowledge, this is the first internation-
ally developed set of perinatal measures that: (a) focuses
on outcomes that matter to women, rather than pro-
cesses of care, (b) includes PROMs, and (c) includes a
set of case-mix factors to facilitate outcome compari-
sons. By involving consumers in our work process and
focusing on the goal of overall wellbeing of mothers and
infants, we identified common pregnancy outcomes and
experiences that may be overlooked by health care pro-
fessionals, but have a major impact on physical and psy-
chological wellbeing.
There were a number of limitations in this work. First,
ICHOM aims to create measure sets that are appropriate
across cultures, applicable in diverse health care settings,
and practical to implement. However, for low-income,
low-resource countries with high rates of mortality and
high levels of morbidity, measurement of comprehensive
perinatal outcomes may be less compelling and too bur-
densome at this time. Accordingly, although the Work-
ing Group represented a diverse range of middle- and
high-income countries, representation from low-income
countries was limited.
Second, it was challenging for the group to identify and
agree on validated measures for each outcome domain. As
discussed above, the Working Group unanimously agreed
that severe maternal morbidity was an important outcome
to include in the measures set. However, agreeing on the
best measures to capture this outcome proved challen-
ging. The “life-threatening condition” approach used by
WHO was considered difficult to implement as it requires
clinical report and may not be representative of severe
morbidity in high-income countries [22]. In contrast, the
approach used by the Center for Disease Control (CDC)
[25] of using administrative data to track the incidence of
25 adverse maternal outcomes was considered too broad
and cumbersome. In addition, the incidence of each of
these adverse outcomes is typically quite low in advanced
economies, limiting the use of this data for quality im-
provement [52]. As a compromise, the Working Group
selected a handful of proxy measures (ICU admission,
length of stay, pregnancy-related readmission, and blood
transfusion) that are easily measured and have been
shown to capture cases of significant adverse maternal
outcomes [23, 53]. While these proxy measures may be
considered processes rather than outcomes, each was con-
sidered an important outcome from the perspective of
women as they each represent a delay in return to normal
activity (prolonged facility stay), cause separation from
their infant (ICU admission and postpartum readmission),
or introduce new risk (blood transfusion).
Similar factors influenced the selection of other new
or non-validated measures for inclusion in the set. The
Working Group recognizes that these measures must be
tested and validated over time, and ICHOM is commit-
ted to supporting this process. Implementors of mea-
sures in this set are encouraged to inform ICHOM of
their work and share their experiences. A Steering Com-
mittee comprised of ICHOM Working Group members
has been assembled to guide the continued maintenance
and refinement of the set based on input from these
early adopters. As measures are refined and implementa-
tion expands, ICHOM will work with implementors to
validate measures as necessary.
Finally, the practicality of measurement and the burden
of data collection in the clinical setting is always an im-
portant consideration. Although data abstracted from ad-
ministrative records may have limited accuracy, capturing
clinical data directly from providers is often prohibitively
burdensome [54, 55]. Therefore, the measure set consists
of a small number of administratively captured data points
and relies heavily upon patient-reported data. This ap-
proach has proven successful in a variety of data collection
efforts around the world [56–58], although capturing
patient-reported outcomes remains a challenge, particu-
larly in low- and middle- income countries. Along with
helping a number of care delivery organizations with im-
plementation of the measure set, ICHOM has partnered
with PharmAccess Foundation to explore the possibility of
using mobile phone technology to enable routine collec-
tion of patient-reported data in Kenya. While the number
of electronic options for collecting such data continues to
expand, distribution of paper surveys within the clinic re-
mains a low-cost option [59].
Conclusions
In conclusion, we expect that the introduction of this
measure set will contribute significantly towards measur-
ing and learning how to increase value in pregnancy and
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postpartum care. In time, providers and maternity care
systems will be able to use such measures to identify ef-
fective, high-value practices across the pregnancy, child-
birth and postpartum periods and to better target
quality improvement efforts. Widespread measurement
and reporting of this data will empower women as active
participants in their care and enable consumers, pro-
viders, and payers to make better-informed decisions
about health care options and spending helping to align
incentives across these stakeholders.
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